Integrated FDG PET/MR imaging for the assessment of myocardial salvage in reperfused acute myocardial infarction

Radiology

Volumn 276, Issue 2, 2015, Pages 400-407

  Nensa, Felix ^a   Poeppel, Thorsten ^a   Tezgah, Ercan ^a   Heusch, Philipp ^b,c   Nassenstein, Kai ^a   Mahabadi, Amir A ^a   Forsting, Michael ^a   Bockisch, Andreas ^a   Erbel, Raimund ^a   Heusch, Gerd ^a   Schlosser, Thomas ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

^c UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT;

ACUTE HEART INFARCTION; ADULT; ARTICLE; CLINICAL ARTICLE; CORONARY ARTERY CIRCUMFLEX BRANCH; CORONARY ARTERY OCCLUSION; DISEASE MARKER; FEMALE; HEART INFARCTION SIZE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PET SCANNER; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; CARDIAC IMAGING; DIAGNOSTIC USE; HEART MUSCLE REPERFUSION; METABOLISM; MIDDLE AGED; MULTIMODAL IMAGING; MYOCARDIAL INFARCTION;

ADULT; CARDIAC IMAGING TECHNIQUES; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIMODAL IMAGING; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; POSITRON-EMISSION TOMOGRAPHY; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS;

EID: 84937593052     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.2015140564     Document Type: Article

References (25)

1. Burns RJ, Gibbons RJ, Yi Q, et al. The relationships of left ventricular ejection fraction, end-systolic volume index and infarct size to six-month mortality after hospital discharge fol lowing myocardial infarction treated by thrombolysis. J Am Coll Cardiol 2002;39(1):30-36.
2. Heusch G. Cardioprotection: chances and challenges of its translation to the clinic. Lancet 2013;381(9861):166-175.
3. Wince WB, Suranyi P, Schoepf UJ. Contemporary cardiovascular imaging methods for the assessment of at-risk myocardium. J Am Heart Assoc 2014;3(1):e000473.
4. Ndrepepa G, Mehilli J, Schwaiger M, et al. Prognostic value of myocardial salvage achieved by reperfusion therapy in patients with acute myocardial infarction. J Nucl Med 2004;45(5):725-729.
5. Kim RJ, Fieno DS, Parrish TB, et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation 1999;100(19):1992-2002.
6. Reimer KA, Jennings RB. The "wavefront phenomenon" of myocardial ischemic cell death: II - transmural progression of necrosis within the framework of ischemic bed size (myocardium at risk) and collateral flow. Lab Invest 1979;40(6):633-644.
7. Wright J, Adriaenssens T, Dymarkowski S, Desmet W, Bogaert J. Quantification of myocardial area at risk with T2-weighted CMR: comparison with contrast-enhanced CMR and coronary angiography. JACC Cardiovasc Imaging 2009;2(7):825-831.
8. Ortiz-Pérez JT, Meyers SN, Lee DC, et al. Angiographic estimates of myocardium at risk during acute myocardial infarction: validation study using cardiac magnetic resonance imaging. Eur Heart J 2007;28(14):1750-1758.
9. Di Carli MF, Prcevski P, Singh TP, et al. Myocardial blood flow, function, and metabolism in repetitive stunning. J Nucl Med 2000;41(7):1227-1234.
10. Nensa F, Poeppel TD, Beiderwellen K, et al. Hybrid PET/MR imaging of the heart: feasibility and initial results. Radiology 2013;268(2):366-373.
11. Fukuoka Y, Nakano A, Uzui H, et al. Reverse blood flow-glucose metabolism mismatch indicates preserved oxygen metabolism in patients with revascularised myocardial infarction. Eur J Nucl Med Mol Imaging 2013;40(8):1155-1162.
12. Aletras AH, Tilak GS, Natanzon A, et al. Retrospective determination of the area at risk for reperfused acute myocardial infarction with T2-weighted cardiac magnetic resonance imaging: histopathological and displacement encoding with stimulated echoes (DENSE) functional validations. Circulation 2006;113(15):1865-1870.
13. Delso G, Fürst S, Jakoby B, et al. Performance measurements of the Siemens mMR integrated whole-body PET/MR scanner. J Nucl Med 2011;52(12):1914-1922.
14. Martinez-Möller A, Souvatzoglou M, Delso G, et al. Tissue classification as a potential approach for attenuation correction in whole-body PET/MRI: evaluation with PET/CT data. J Nucl Med 2009;50(4):520-526.
15. Ridler TW, Calvard S. Picture thresholding using an iterative selection method. IEEE Trans Syst Man Cybern 1978;8(8):630-632.
16. Vermes E, Childs H, Carbone I, Barckow P, Friedrich MG. Auto-threshold quantification of late gadolinium enhancement in patients with acute heart disease. J Magn Reson Imaging 2013;37(2):382-390.
17. Arai AE, Leung S, Kellman P. Controversies in cardiovascular MR imaging: reasons why imaging myocardial T2 has clinical and pathophysiologic value in acute myocardial infarction. Radiology 2012;265(1):23-32.
18. Berry C, Kellman P, Mancini C, et al. Magnetic resonance imaging delineates the ischemic area at risk and myocardial salvage in patients with acute myocardial infarction. Circ Cardiovasc Imaging 2010;3(5):527-535.
19. Ubachs JF, Engblom H, Erlinge D, et al. Cardiovascular magnetic resonance of the myocardium at risk in acute reperfused myocardial infarction: comparison of T2-weighted imaging versus the circumferential endocardial extent of late gadolinium enhancement with transmural projection. J Cardiovasc Magn Reson 2010;12:18.
20. Croisille P, Kim HW, Kim RJ. Controversies in cardiovascular MR imaging: T2-weighted imaging should not be used to delineate the area at risk in ischemic myocardial injury. Radiology 2012;265(1):12-22.
21. Lee JT, Ideker RE, Reimer KA. Myocardial infarct size and location in relation to the coronary vascular bed at risk in man. Circulation 1981;64(3):526-534.
22. Heusch G. Hibernating myocardium. Physiol Rev 1998;78(4):1055-1085.
23. Heusch G, Schulz R, Rahimtoola SH. Myocardial hibernation: a delicate balance. Am J Physiol Heart Circ Physiol 2005;288(3):H984-H999.
24. Anselm DD, Anselm AH, Renaud J, et al. Altered myocardial glucose utilization and the reverse mismatch pattern on rubidium-82 perfusion/F-18-FDG PET during the sub-acute phase following reperfusion of acute a;nterior myocardial infarction. J Nucl Cardiol 2011;18(4):657-667.
25. Liedtke AJ, DeMaison L, Eggleston AM, Cohen LM, Nellis SH. Changes in substrate metabolism and effects of excess fatty acids in reperfused myocardium. Circ Res 1988;62(3):535-542.